The emerging link between autoimmune disorders and neuropsychiatric disease

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 23, Issue 1, 2011, Pages 90-97

  Kayser, Matthew S ^a   Dalmau, Josep ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; ALPHA CRYSTALLIN; AMPA RECEPTOR; CARDIOLIPIN; CD45RO ANTIGEN; CONTACTIN ASSOCIATED PROTEIN LIKE 2; FODRIN; LA ANTIGEN; LEUCINE RICH GLIOMA INACTIVATED 1 PROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROTEIN; RIBOSOMAL PROTEIN L1; UNCLASSIFIED DRUG;

ACUTE BRAIN DISEASE; AFFECTIVE PSYCHOSIS; AGITATION; ALLERGIC ENCEPHALOMYELITIS; AMNESIA; ANXIETY DISORDER; APATHY; ARTICLE; AUTONOMIC DYSFUNCTION; BEHAVIOR DISORDER; BEHCET DISEASE; BREAST CANCER; CATATONIA; COGNITIVE DEFECT; CONFUSION; DELIRIUM; DISEASE ASSOCIATION; DISORIENTATION; DYSAUTONOMIA; DYSKINESIA; ENDOTHELIUM CELL; HALLUCINATION; HEADACHE; HEARING LOSS; HUMAN; HYPONATREMIA; HYPOVENTILATION; INTESTINE LIPODYSTROPHY; IRRITABILITY; LUNG CANCER; LUNG SMALL CELL CANCER; MEMORY DISORDER; MULTIPLE SCLEROSIS; MYOTONIA; NEUROPATHY; OVARY TERATOMA; PARANOIA; PERIPHERAL NEUROPATHY; PERSONALITY DISORDER; PRIORITY JOURNAL; PSYCHOSIS; RETINA ARTERY OCCLUSION; SEIZURE; SJOEGREN SYNDROME; SPEECH DISORDER; STROKE; SUSAC SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; TERATOMA; TREATMENT OUTCOME; VASCULITIS; WEIGHT REDUCTION;

ANIMALS; AUTOIMMUNE DISEASES; BRAIN; ENCEPHALITIS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MENTAL DISORDERS; RECEPTORS, AMPA; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 80052197369     PISSN: 08950172     EISSN: 15457222     Source Type: Journal    
DOI: 10.1176/appi.neuropsych.23.1.90     Document Type: Article

References (72)

1. Goldsmith CA, Rogers DP: The case for autoimmunity in the etiology of schizophrenia. Pharmacotherapy 2008; 28: 730-741
2. Ching KH, Burbelo PD, Carlson PJ, et al: High levels of anti-GAD65 and anti-Ro52 autoantibodies in a patient with major depressive disorder showing psychomotor disturbance. J Neuroimmunol 2010; 222:87-89
3. Nemeroff CB, Simon JS, Haggerty JJ Jr, et al: Antithyroid antibodies in depressed patients. Am J Psychiatry 1985; 142: 840-843
4. Roos RP, Davis K, Meltzer HY: Immunoglobulin studies in patients with psychiatric diseases. Arch Gen Psychiatry 1985; 42:124-128
5. Diamond B, Huerta PT, Mina-Osorio P, et al: Losing your nerves? Maybe it's the antibodies. Nat Rev Immunol 2009; 9:449-456
6. Moscato EH, Jain A, Peng X, et al: Mechanisms underlying autoimmune synaptic encephalitis leading to disorders of memory, behavior and cognition: insights from molecular, cellular and synaptic studies. Eur J Neurosci 2010; 32:298-309
7. Kayser MS, Kohler CG, Dalmau J: Psychiatric manifestations of paraneoplastic disorders. Am J Psychiatry 2010; 167:1039-1050
8. Tuzun E, Dalmau J: Limbic encephalitis and variants: classification, diagnosis, and treatment. Neurologist 2007; 13:261-271
9. Dalmau J, Gleichman AJ, Hughes EG, et al: Anti-NMDAreceptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008; 7:1091-1098
10. Dalmau J, Tuzun E, Wu HY, et al: Paraneoplastic anti-Nmethyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007; 61:25-36
11. Florance NR, Davis RL, Lam C, et al: Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol 2009; 66:11-18
12. Sansing LH, Tuzun E, Ko MW, et al: A patient with encephalitis associated with NMDA receptor antibodies. Nat Clin Pract Neurol 2007; 3:291-296
13. Sebire G: In search of lost time from "demonic possession" to anti-N-methyl-D-aspartate receptor encephalitis. Ann Neurol 2010; 67:141-142; author reply 142-143
14. Hughes EG, Peng X, Gleichman AJ, et al: Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci 2010; 30:5866-5875
15. Dalmau J, Rosenfeld MR: Paraneoplastic syndromes of the CNS. Lancet Neurol 2008; 7:327-340
16. Chapman M,Vause H: NMDAR Encephalitis: Diagnosis, Psychiatric Presentation, and Treatment. Am J Psychiatry (in press)
17. Kessels HW, Malinow R: Synaptic AMPA receptor plasticity and behavior. Neuron 2009; 61:340-350
18. Bowers MS, Chen BT, Bonci A: AMPA receptor synaptic plasticity induced by psychostimulants: the past, present, and therapeutic future. Neuron 2010; 67:11-24
19. Vialou V, Robison AJ, Laplant QC, et al: Deltafosb in brain reward circuits mediates resilience to stress and antidepressant responses. Nat Neurosci 2010; 13:745-752
20. Lai M, Hughes EG, Peng X, et al: AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol 2009
21. Graus F, Boronat A, Xifro X, et al: The expanding clinical profile of anti-AMPA receptor encephalitis. Neurology 2010; 74:857-859
22. Bataller L, Galiano R, Garcia-Escrig M, et al: Reversible paraneoplastic limbic encephalitis associated with antibodies to the AMPA receptor. Neurology 2010; 74:265-267
23. Hunter R, Jones M, Malleson A: Abnormal cerebrospinal fluid total protein and gamma-blobulin levels in 256 patients admitted to a psychiatric unit. J Neurol Sci 1969; 9:11-38
24. Lancaster E, Lai M, Peng X, et al: Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterization of the antigen. Lancet Neurol 2009
25. Mombereau C, Kaupmann K, Froestl W, et al: Genetic and pharmacological evidence of a role for GABA(B) receptors in the modulation of anxiety-and antidepressant-like behavior. Neuropsychopharmacology 2004; 29:1050-1062
26. Dalva MB, McClelland AC, Kayser MS: Cell adhesion molecules: signaling functions at the synapse. Nat Rev Neurosci 2007; 8:206-220
27. Glessner JT, Wang K, Cai G, et al: Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature 2009; 459:569-573
28. Rujescu D, Ingason A, Cichon S, et al: Disruption of the neurexin 1 gene is associated with schizophrenia. Hum Mol Genet 2009; 18:988-996
29. Fukata Y, Adesnik H, Iwanaga T, et al: Epilepsy-related ligand/ receptor complex LGI1 and adam22 regulate synaptic transmission. Science 2006; 313:1792-1795
30. Lai M, Huijbers MG, Lancaster E, et al: Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol 2010; 9:776-785
31. Kalachikov S, Evgrafov O, Ross B, et al: Mutations in LGI1 cause autosomal-dominant partial epilepsy with auditory features. Nat Genet 2002; 30:335-341
32. Winawer MR, Ottman R, Hauser WA, et al: Autosomal dominant partial epilepsy with auditory features: defining the phenotype. Neurology 2000; 54:2173-2176
33. Irani SR, Alexander S, Waters P, et al: Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia Brain 2010; 133:2734-2748
34. Thieben MJ, Lennon VA, Boeve BF, et al: Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody. Neurology 2004; 62:1177-1182
35. Vincent A, Buckley C, Schott JM, et al: Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 2004; 127:701-712
36. Poliak S, Gollan L, Martinez R, et al: Caspr2, a new member of the neurexin superfamily, is localized at the juxtaparanodes of myelinated axons and associates with K channels. Neuron 1999; 24:1037-1047
37. Sudhof TC: Neuroligins and neurexins link synaptic function to cognitive disease. Nature 2008; 455:903-911
38. Strauss KA, Puffenberger EG, Huentelman MJ, et al: Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2. N Engl J Med 2006; 354:1370-1377
39. Lancaster E, Huijbers M, Bar V, et al:Investigations of Caspr2, an autoantigen of encephalitis and neuromyotonia. Ann Neurol (in press)
40. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999; 42:599-608
41. Ainiala H, Loukkola J, Peltola J, et al: The prevalence of neu-ropsychiatric syndromes in systemic lupus erythematosus. Neurology 2001; 57:496-500
42. Brey RL, Holliday SL, Saklad AR, et al: Neuropsychiatric syndromes in lupus: prevalence using standardized definitions. Neurology 2002; 58:1214-1220
43. Hanly JG, Urowitz MB, Su L, et al: Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus. Ann Rheum Dis 2010; 69:529-535
44. Aranow C, Diamond B, Mackay M: Glutamate receptor biology and its clinical significance in neuropsychiatric systemic lupus erythematosus. Rheum Dis Clin North Am 2010; 36: 187-201, x-xi
45. Bonfa E, Golombek SJ, Kaufman LD, et al: Association between lupus psychosis and anti-ribosomal P protein antibodies. N Engl J Med 1987; 317:265-271
46. Matus S, Burgos PV, Bravo-Zehnder M, et al: Antiribosomal-P autoantibodies from psychiatric lupus target a novel neuronal surface protein causing calcium influx and apoptosis. J Exp Med 2007; 204:3221-3234
47. Karassa FB, Afeltra A, Ambrozic A, et al: Accuracy of antiribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis. Arthritis Rheum 2006; 54:312-324
48. Eber T, Chapman J, Shoenfeld Y: Anti-ribosomal P-protein and its role in psychiatric manifestations of systemic lupus erythematosus: myth or reality? Lupus 2005; 14:571-575
49. DeGiorgio LA, Konstantinov KN, Lee SC, et al: A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med 2001; 7:1189-1193
50. Lau CG, Zukin RS: Nmda receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat Rev Neurosci 2007; 8:413-426
51. Kowal C, Degiorgio LA, Lee JY, et al: Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc Natl Acad Sci U S A 2006; 103:19854-19859
52. Saux A, Niango G, Charif M, et al: Susac's syndrome, a rare, potentially severe or lethal neurological disease. J Neurol Sci 2010; 297:71-73
53. Susac JO, Egan RA, Rennebohm RM, et al: Susac's syndrome: 1975-2005 microangiopathy/autoimmune endotheliopathy. J Neurol Sci 2007; 257:270-272
54. O'Halloran HS, Pearson PA, Lee WB, et al: Microangiopathy of the brain, retina, and cochlea (Susac syndrome): a report of five cases and a review of the literature Ophthalmology 1998; 105:1038-1044
55. Hahn JS, Lannin WC, Sarwal MM: Microangiopathy of brain, retina, and inner ear (Susac's syndrome) in an adolescent female presenting as acute disseminated encephalomyelitis. Pediatrics 2004; 114:276-281
56. Jarius S, Neumayer B, Wandinger KP, et al: Anti-endothelial serum antibodies in a patient with Susac's syndrome. J Neurol Sci 2009; 285:259-261
57. Birnbaum J, Hellmann DB: Primary angiitis of the central nervous system. Arch Neurol 2009; 66:704-709
58. MacLaren K, Gillespie J, Shrestha S, et al: Primary angiitis of the central nervous system: emerging variants. QJM 2005; 98: 643-654
59. Salvarani C, Brown RD Jr, Calamia KT, et al: Primary central nervous system vasculitis: analysis of 101 patients. Ann Neurol 2007; 62:442-451
60. Berlit P: Neuropsychiatric disease in collagen vascular diseases and vasculitis. J Neurol 2007; 254(suppl 2):II87-89
61. Fenollar F, Puechal X, Raoult D: Whipple's disease. N Engl J Med 2007; 356:55-66
62. Schwartz MA, Selhorst JB, Ochs AL, et al: Oculomasticatory myorhythmia: a unique movement disorder occurring in Whipple's disease. Ann Neurol 1986; 20:677-683
63. Panegyres PK, Edis R, Beaman M, et al: Primary Whipple's disease of the brain: characterization of the clinical syndrome and molecular diagnosis. QJM 2006; 99:609-623
64. Panegyres PK, Foster JK, Fallon M, et al: The amnesic syndrome of primary Whipple disease of the brain. Cogn Behav Neurol 2010; 23:49-51
65. Leesch W, Fischer I, Staudinger R, et al: Primary cerebral Whipple disease presenting as Kluver-Bucy syndrome. Arch Neurol 2009; 66:130-131
66. Alexander EL, Ranzenbach MR, Kumar AJ, et al: Anti-Ro(SS-A) autoantibodies in central nervous system disease associated with Sjögren's syndrome (CNS-SS): clinical, neuroimaging, and angiographic correlates. Neurol 1994; 44:899-908
67. de Seze J, Dubucquoi S, Fauchais AL, et al: Autoantibodies against alpha-fodrin in Sjögren's syndrome with neurological manifestations. J Rheumatol 2004; 31:500-503
68. Delalande S, de Seze J, Fauchais AL, et al: Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients. Med (Baltimore) 2004; 83:280-291
69. Lafitte C, Amoura Z, Cacoub P, et al: Neurological complications of primary Sjögren's syndrome. J Neurol 2001; 248:577-584
70. Celet B, Akman-Demir G, Serdaroglu P, et al: Anti-alpha Bcrystallin immunoreactivity in inflammatory nervous system diseases. J Neurol 2000; 247:935-939
71. Oktem-Tanor O, Baykan-Kurt B, Gurvit IH, et al: Neuropsychological follow-up of 12 patients with neuro-Behc ̧et disease. J Neurol 1999; 246:113-119
72. Wang CR, Chuang CY, Chen CY: Anticardiolipin antibodies and interleukin-6 in cerebrospinal fluid and blood of Chinese patients with neuro-Behc ̧et's syndrome. Clin Exp Rheumatol 1992; 10:599-602.